Exodus Point Capital Management, LP Travere Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$15.3 - $22.61 $6.06 Million - $8.95 Million	396,060 New	396,060 $6.08 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $3.03 Million - $4.29 Million	163,993 New	163,993 $3.45 Million
Q1 2022 May 13, 2022	SELL	$23.61 - $30.6 $923,623 - $1.2 Million	-39,120 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$24.34 - $31.17 $952,180 - $1.22 Million	39,120 New	39,120 $1.21 Million
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $172,283 - $234,208	-7,372 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $141,321 - $205,457	7,372 New	7,372 $201,000

214

94.3M

1.2M

778K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.32B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.